Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 30
1999 61
2000 101
2001 97
2002 172
2003 217
2004 310
2005 285
2006 353
2007 300
2008 365
2009 348
2010 407
2011 406
2012 590
2013 664
2014 629
2015 575
2016 591
2017 623
2018 568
2019 434
2020 535
2021 438
2022 336
2023 316
2024 128

Text availability

Article attribute

Article type

Publication date

Search Results

9,877 results

Results by year

Filters applied: . Clear all
Page 1
Current Design of New Psychoactive Substances.
Busardò FP, Zaami S. Busardò FP, et al. Curr Pharm Des. 2022;28(15):1211-1212. doi: 10.2174/138161282815220624141644. Curr Pharm Des. 2022. PMID: 35899910 No abstract available.
Antibiotic Resistance and Microbiota Response.
Santacroce L, Di Domenico M, Montagnani M, Jirillo E. Santacroce L, et al. Curr Pharm Des. 2023;29(5):356-364. doi: 10.2174/1381612829666221219093450. Curr Pharm Des. 2023. PMID: 36537602 Review.
Natural Compounds Used for Treating Hair Loss.
Gasmi A, Mujawdiya PK, Beley N, Shanaida M, Lysiuk R, Lenchyk L, Noor S, Muhammad A, Strus O, Piscopo S, Komisarenko A, Fedorovska M, Bjørklund G. Gasmi A, et al. Curr Pharm Des. 2023;29(16):1231-1244. doi: 10.2174/1381612829666230505100147. Curr Pharm Des. 2023. PMID: 37151166 Review.
Drug-induced Anaphylaxis.
Labella M, de Santa María RS, Bogas G, Salas M, Fernández TD, Mayorga C, Torres MJ, Doña I. Labella M, et al. Curr Pharm Des. 2023;29(3):196-208. doi: 10.2174/1381612829666221024154951. Curr Pharm Des. 2023. PMID: 36284381 Review.
New Therapeutic Options for Migraine.
Tana C, Cipollone F, Giamberardino MA. Tana C, et al. Curr Pharm Des. 2023;29(25):1964-1966. doi: 10.2174/1381612829666230821092238. Curr Pharm Des. 2023. PMID: 37605392 No abstract available.
Natural Products as Health Promoters.
Barros L, Heleno SA, Prieto MA. Barros L, et al. Curr Pharm Des. 2023;29(11):803. doi: 10.2174/138161282911230427152736. Curr Pharm Des. 2023. PMID: 37231713 No abstract available.
PCSK9 Inhibition in Atherosclerotic Cardiovascular Disease.
Delialis D, Dimopoulou MA, Papaioannou M, Kotsira G, Maneta E, Mavraganis G, Loutos C, Georgiopoulos G, Stamatelopoulos K. Delialis D, et al. Curr Pharm Des. 2023;29(23):1802-1824. doi: 10.2174/1381612829666230412105238. Curr Pharm Des. 2023. PMID: 37055909 Review.
Multiphasic Gels: Achieving New Drug Delivery.
Pandey M, Saraf SA, Saraf SK. Pandey M, et al. Curr Pharm Des. 2023;29(40):3171. doi: 10.2174/138161282940231220112709. Curr Pharm Des. 2023. PMID: 38173055 No abstract available.
9,877 results